Neutrophil Extracellular Traps May Augur Severe COVID-19
Neutrophil Extracellular Traps May Augur Severe COVID-19
These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.
Neutrophil Extracellular Traps May Augur Severe COVID-19
Neutrophil Extracellular Traps May Augur Severe COVID-19

These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.

These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.

yeast, genetics, genetics & genomics, immunology
First US Outbreak of COVID-19 Seeded in Mid-February: Preprint
First US Outbreak of COVID-19 Seeded in Mid-February: Preprint
Kerry Grens | May 27, 2020
A modeling study counters initial interpretations that the cluster began with someone who flew to Seattle in mid-January.
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
Katarina Zimmer | May 26, 2020
There is no evidence that any of the coronavirus vaccines in development worsen a coronavirus infection rather than confer immunity to it, but the phenomenon is something scientists are closely monitoring.
Alzheimer’s Gene Linked to Higher Risk of Severe COVID-19
Alzheimer’s Gene Linked to Higher Risk of Severe COVID-19
Jef Akst | May 26, 2020
Two copies of the APOE4 variant, which confers a higher risk of dementia, doubles the risk of severe symptoms as a result of infection with SARS-CoV-2, according to a study.
Environmental Factors Don’t Explain Rise in Autism Prevalence
Environmental Factors Don’t Explain Rise in Autism Prevalence
Peter Hess | May 22, 2020
A large twin study in Sweden finds genetics has a much larger influence on the odds of an autism diagnosis, and has remained consistent over time.
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
SARS-CoV-2 Protein Hampers Innate Immune Reaction In Vitro
Abby Olena | May 21, 2020
The viral protein known as ORF3b limits the induction of the type I interferon response, which typically alerts other immune system components to the presence of a virus, in cultured cells.
Losing Touch: Another Drawback of the COVID-19 Pandemic
Losing Touch: Another Drawback of the COVID-19 Pandemic
Ashley Yeager | May 19, 2020
Affectionate touches tap into the nervous system’s rest and digest mode, reducing the release of stress hormones, bolstering the immune system, and stimulating brainwaves linked with relaxation.
Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data
Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data
Ashley Yeager | May 18, 2020
A clinical trial of the shot in eight volunteers suggests that it is safe and that it generates antibodies that neutralize SARS-CoV-2, but further testing is needed, scientists say.
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
Shawna Williams | May 15, 2020
While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.
Loss of Smell, Taste May Be Reliable Predictor of COVID-19: Study
Loss of Smell, Taste May Be Reliable Predictor of COVID-19: Study
Ashley Yeager | May 12, 2020
Data from a crowdsourcing smartphone app is helping to track the spread of the disease in real time and reveals the symptom as the number one indicator of infection.